Apricity Therapeutics Overview

  • Founded
  • 2012
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $190K
Latest Deal Amount
  • Investors
  • 3

Apricity Therapeutics General Information


Provider of treatment for pediatric orphan cancers. The company allows cancer patients to receive larger doses of chemotherapy push chemotherapy agents directly to tumors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Therapeutic Devices
Other Industries
Clinics/Outpatient Services
Primary Office
  • 67 Jennings Lane
  • Atherton, CA 94027
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Apricity Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 02-Apr-2014 $190K Completed Startup
3. Grant 24-Sep-2012 00000 Completed Startup
2. Accelerator/Incubator 19-Sep-2012 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Apricity Therapeutics’s complete valuation and funding history, request access »

Apricity Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
Kathleen Giacomini Ph.D Co-Founder, Board of Director & Scientific Advisor
You’re viewing 1 of 3 executive team members. Get the full list »

Apricity Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
California Institute for Quantitative Biosciences Accelerator/Incubator 000 0000 000000 0
JLABS Accelerator/Incubator 000 0000 000000 0
To view Apricity Therapeutics’s complete investors history, request access »